Ketamine

16.95 JOD

Please allow 2 – 5 weeks for delivery of this item

Description

The emergence of ketamine–previously known as a combat anesthetic and club drug–as a treatment for depression.Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years–in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug–that has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.

Additional information

Weight 0.1589 kg
Dimensions 1.3716 × 12.7 × 17.78 cm
by

format

Language

Pages

208

publisher

Year Published

2021-2-16

Imprint

Publication City/Country

USA

ISBN 10

0262542242

About The Author

Bita Moghaddam is a leading researcher in the field of neuropsychopharmacology. She is Ruth Matarazzo Professor of Behavioral Neuroscience at Oregon Health and Science University in Portland.

Table Of Content

Series Foreword ix Preface xi 1 The Molecule Ketamine 1 2 Uses of Ketamine 17 3 Neuroscience of Ketamine 31 4 Ketamine as an Antidepressant 65 5 How Does Ketamine Produce Antidepressant Effects? 101 6 Safety Concerns with Ketamine and Esketamine 121 7 Where Do We Go from Here? 141 Acknowledgments 155 Glossary 157 Notes 161 Further Reading 177 Index 179

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.